All News
Canadian Vaccination Guidelines for the Immunosuppressed
A multidisciplinary Canadian task force has developed guidelines for vaccination in patients receiving immunosuppressive therapies, based on the evidence that immunosuppressive use in immune-mediated disease may be associated with an elevated risk of infections.
Read ArticleFDA Slaps a Boxed Warning on Febuxostat for CV Risk
The U.S. Food and Drug Administration (FDA) has reviewed data from the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES) trial and concluded there is an increased risk of death with Uloric (febuxostat) compared with allopurinol, and has added this as a boxed warning to the drug’s product label.
Read ArticleThe Risk of Tuberculosis with TNF Inhibitors
A study from Turkey shows that among 2117 patients treated with a TNF inhibitor (TNFi) the risk of developing TB was 6 fold higher in those treated with a TNFi compared to non-users.
Read ArticleRheumNow Podcast - Death and Surgery (2-22-19)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com:
Read ArticleLupus Microbiome May Drive Disease Activity
Silverman and colleagues have published their study of the fecal microbiome of systemic lupus erythematosus (SLE) patients and found roughly five times more gut bacteria known as Ruminococcus gnavus, and that these abnormalities in microbiota can correlate with measures of disease severity i
Read ArticleImpressive Survival of Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
The drug retention rate of interleukin-1 inhibitors (IL-1) used to treat systemic juvenile idiopathic arthritis (JIA) appears to be quite high according to a new study.
Read Article![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Links:
Dr. John Cush RheumNow ( View Tweet)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Links:
Dr. John Cush RheumNow ( View Tweet)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Links:
Dr. John Cush RheumNow ( View Tweet)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Dr. John Cush RheumNow ( View Tweet)
![](https://pbs.twimg.com/media/D0HZQXBWkAAQ4aV.jpg)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Links:
Dr. John Cush RheumNow ( View Tweet)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Dr. John Cush RheumNow ( View Tweet)
![](https://pbs.twimg.com/profile_images/926433283193425920/cOMunlL6.jpg)
k dao KDAO2011 ( View Tweet)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Links:
Dr. John Cush RheumNow ( View Tweet)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Links:
Dr. John Cush RheumNow ( View Tweet)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Dr. John Cush RheumNow ( View Tweet)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Links:
Dr. John Cush RheumNow ( View Tweet)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Links:
Dr. John Cush RheumNow ( View Tweet)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Links:
Dr. John Cush RheumNow ( View Tweet)